Ocado dealt 'dreadful blow' as Kroger closes three robot warehouses — Negative

KR  OCDDY  OCDGF   Proactive Investors — November 18, 2025

Ocado Group PLC (LSE:OCDO) shares slumped over 19% to 174p, around lows last seen over a decade ago, after US grocery client Kroger said it would shut down three of the warehouses that rely on the online grocery supplier's technology. Kroger Co (NYSE:KR) announced that it will close three operating customer fulfilment centres, in Frederick, Maryland; Pleasant Prairie, Wisconsin; and Groveland, Florida by January.

image for news Ocado dealt 'dreadful blow' as Kroger closes three robot warehouses

Nvidia, Microsoft invest $15 billion in AI startup Anthropic — Positive

MSFT  NVDA   TechXplore — November 18, 2025

Chip giant Nvidia and Microsoft announced Tuesday investments totaling $15 billion in AI startup Anthropic, creator of the Claude chatbot, as the AI investment frenzy continues amid emerging fears of a bubble on Wall Street.

image for news Nvidia, Microsoft invest $15 billion in AI startup Anthropic

Sophos integrates Intelix threat intelligence into Microsoft Security Copilot and 365 Copilot, empowering global defenders with AI-driven cybersecurity.

image for news Sophos Integrates Advanced Cyber Intelligence into Microsoft Security Copilot and Microsoft 365 Copilot

COPENHAGEN, Denmark; November 18, 2025 – Genmab A/S (Nasdaq: GMAB) announced today that EPKINLY® (epcoritamab-bysp) in combination with rituximab and lenalidomide (EPKINLY + R2) was approved by the U.S. Food and Drug Administration (FDA) for adult patients with relapsed or refractory (R/R) follicular lymphoma (FL). The approval is based on results from the pivotal Phase 3 EPCORE® FL-1 study that evaluated fixed duration EPKINLY + R2 compared to standard of care R2.i

image for news Genmab Announces EPKINLY® (epcoritamab-bysp) in Combination with Rituximab and Lenalidomide Approved by the U.S. Food and Drug Administration for the Treatment of Relapsed or Refractory Follicular Lymphoma

SAN FRANCISCO--(BUSINESS WIRE)--ServiceNow advances enterprise AI through seamless integrations with Microsoft, enabling collaboration, orchestration, and governance.

image for news ServiceNow Advances Enterprise AI through Seamless Integrations with Microsoft, Enabling Collaboration, Orchestration, and Governance

OXFORD, United Kingdom, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Sophos , a global leader of innovative security solutions for defeating cyberattacks, today announced its integration with Microsoft Defender for Business, Microsoft Defender for Endpoint, and that its Sophos MDR for Microsoft environments solution has achieved Microsoft verified Small & Medium Business (SMB) solution status through the Microsoft Intelligent Security Association (MISA). Microsoft's verified SMB Solution status highlights the crucial role of partner collaboration in protecting small and medium businesses against increasing cyberattacks.

image for news Sophos Recognized with Microsoft Verified Small and Medium Business (SMB) Solution Status

Merck Announces First-Quarter 2026 Dividend — Neutral

MRK   Business Wire — November 18, 2025

RAHWAY, N.J.--(BUSINESS WIRE)--Merck Announces First-Quarter 2026 Dividend.

image for news Merck Announces First-Quarter 2026 Dividend

WEX Inc. (WEX) Presents at Citi's 14th Annual FinTech Conference Transcript — Neutral

WEX   Seeking Alpha — November 18, 2025

WEX Inc. ( WEX ) Citi's 14th Annual FinTech Conference November 18, 2025 9:00 AM EST Company Participants Melissa Smith - Chairman of the Board, President & CEO Conference Call Participants Aditi Balachandran Presentation Aditi Balachandran So welcome to Citi's 14th Annual FinTech Conference. My name is Aditi Balachandran and I'm with Citi Research, and I have the pleasure to introduce Melissa Smith, Chair and CEO of WEX.

image for news WEX Inc. (WEX) Presents at Citi's 14th Annual FinTech Conference Transcript

Elbit Systems Ltd. (ESLT) Q3 2025 Earnings Call Transcript — Neutral

ESLT   Seeking Alpha — November 18, 2025

Elbit Systems Ltd. ( ESLT ) Q3 2025 Earnings Call November 18, 2025 9:00 AM EST Company Participants Daniella Finn - Vice President of Investor Relations Yaacov Kagan - Executive VP & CFO Bezhalel Machlis - President & CEO Conference Call Participants Jordan Lyonnais - BofA Securities, Research Division Seth Seifman - JPMorgan Chase & Co, Research Division Ellen Page - Jefferies LLC, Research Division Presentation Operator Ladies and gentlemen, thank you for standing by.

image for news Elbit Systems Ltd. (ESLT) Q3 2025 Earnings Call Transcript

Align Technology, Inc. ( ALGN ) Jefferies London Healthcare Conference 2025 November 18, 2025 5:30 AM EST Company Participants John Morici - CFO & Executive VP of Global Finance Joseph Hogan - President, CEO & Director Presentation Unknown Analyst I'm an analyst on the U.S. Medical Supplies and Devices team, and this is a session for Align Technology. From the company, we've got Joe Hogan, President and CEO; John Morici, CFO; and we've also got Shirley Stacy here as well.

image for news Align Technology, Inc. (ALGN) Presents at Jefferies London Healthcare Conference 2025 Transcript

The most anticipated quarterly earnings of the month will be announced on Wednesday, November 19, as AI chip giant Nvidia Corporation (Nasdaq: NVDA) reveals financial results for its 2026 fiscal third quarter.

image for news Nvidia earnings: As AI stocks slide and Wall Street holds its breath, here's what top analysts expect

Why Oracle And Salesforce Look Stronger Than Synopsys Right Now — Positive

CRM  ORCL   Forbes — November 18, 2025

ORCL and CRM are Synopsys's competitors in the Application Software industry that possess:

image for news Why Oracle And Salesforce Look Stronger Than Synopsys Right Now

ATLANTA, Nov. 18, 2025 (GLOBE NEWSWIRE) -- A shareholder class action lawsuit has been filed against Skye Bioscience, Inc. ("Skye" or the "Company") (NASDAQ: SKYE). The lawsuit alleges that Defendants made materially false and/or misleading statements and/or failed to disclose key facts, including allegations that: (1) nimacimab was less effective than Defendants had led investors to believe; (2) accordingly, nimacimab's clinical, regulatory, and commercial prospects were overstated; and (3) as a result, Defendants' public statements were materially false and misleading at all relevant times.

image for news INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of Skye Bioscience, Inc.Investors – Holzer & Holzer, LLC Encourages Investors With Significant Losses to Contact the Firm

Home Depot Says Focus on B2B Fails to Boost Results — Negative

HD   PYMNTS — November 18, 2025

When it comes to consumer and corporate confidence, the bellwethers are increasingly ringing the alarm. That was the case on Home Depot's third-quarter 2025 investor earnings call Tuesday (Nov. 18).

image for news Home Depot Says Focus on B2B Fails to Boost Results

4 GARP Stocks That Investors Can Scoop Up for Maximum Returns — Positive

AXP  POWL  RGLD  RL   Zacks Investment Research — November 18, 2025

Try the GARP strategy when seeking a profitable portfolio of stocks offering optimum value and growth investing. RL, RGLD, POWL and AXP hold promise.

image for news 4 GARP Stocks That Investors Can Scoop Up for Maximum Returns

LOS ANGELES, Nov. 18, 2025 (GLOBE NEWSWIRE) -- The Schall Law Firm , a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Firefly Aerospace Inc. (“Firefly” or “the Company”) (NASDAQ: FLY) for violations of the federal securities laws. Investors who purchased the Company's securities pursuant and/or traceable to the Company's Offering Documents issued in connection with its initial public offering (“IPO”) conducted on August 7, 2025, and/or between August 7, 2025 and September 29, 2025, both dates inclusive (the "Class Period"), are encouraged to contact the firm before January 12, 2026.

image for news FLY Investors Have Opportunity to Lead Firefly Aerospace Inc. Securities Fraud Lawsuit with the Schall Law Firm

WILBRAHAM, Mass.--(BUSINESS WIRE)--Aceso Interactive, Inc., a leader in patient experience and engagement solutions, today announced a strategic partnership with HP, Inc. (NYSE: HPQ), integrating the full capabilities of the Aceso Interactive Patient Care Platform and Pane of Glass™ toolkit with HP | Poly video collaboration solutions. This integration marks a significant milestone in advancing world-class video conferencing, and market-leading patient engagement solutions. The Aceso and HP sol.

image for news Aceso Interactive Partners with HP to Deliver Scalable Patient Collaboration and Engagement Platform

S&P Global Inc. ( SPGI ) J.P. Morgan 2025 Ultimate Services Investor Conference November 18, 2025 9:00 AM EST Company Participants Martina Cheung - President, CEO & Director Conference Call Participants Andrew Steinerman - JPMorgan Chase & Co, Research Division Presentation Andrew Steinerman JPMorgan Chase & Co, Research Division All right.

image for news S&P Global Inc. (SPGI) Presents at J.P. Morgan 2025 Ultimate Services Investor Conference Transcript

BlackBerry Limited ( BB:CA ) Global Technology, Internet, Media & Telecommunications Conference 2025 November 18, 2025 9:20 AM EST Company Participants John Giamatteo - CEO & Director Tim Foote - Chief Financial Officer Conference Call Participants Paul Treiber - RBC Capital Markets, Research Division Presentation Paul Treiber RBC Capital Markets, Research Division So thanks, everyone, for joining us. My name is Paul Treiber for anyone who doesn't know me.

image for news BlackBerry Limited (BB:CA) Presents at Global Technology, Internet, Media & Telecommunications Conference 2025 Transcript

Repligen Corporation ( RGEN ) Jefferies London Healthcare Conference 2025 November 18, 2025 8:30 AM EST Company Participants Olivier Loeillot - President, CEO & Director Conference Call Participants Matthew Stanton - Jefferies LLC, Research Division Presentation Matthew Stanton Jefferies LLC, Research Division Thanks. My name is Matt Stanton.

image for news Repligen Corporation (RGEN) Presents at Jefferies London Healthcare Conference 2025 Transcript